Purchase Order 75N93021P00492

The National Institute of Allergy and Infectious Diseases issued a delivery order to Becton, Dickinson and Company on July 5, 2019, for fluorescently conjugated monoclonal antibodies and flow cytometry custom conjugates and consumables for vaccine research and pre-clinical monitoring, with a ceiling value of $6,425.00. Place of performance is San Jose, CA. Ultimate completion date is August 9, 2019. The order is priced on a firm fixed price basis and was issued without a set-aside.

<p>The National Institute of Allergy and Infectious Diseases issued a delivery order to Becton, Dickinson and Company on May 2, 2018, with a ceiling value of $11,640.30 for fluorescently conjugated monoclonal antibodies for research and pre-clinical monitoring of vaccine applications.</p> <p>Place of performance is San Jose, CA. Ultimate completion date is May 4, 2018. The order is priced on a firm fixed price basis with no set-aside applied.</p>

<p>The National Institute of Allergy and Infectious Diseases issued a $21,515 delivery order to Becton, Dickinson and Company (BD Biosciences) on March 28, 2018, for fluorescently conjugated monoclonal antibodies and flow cytometry consumables for the Vaccine Research Center.</p> <p>Place of performance is San Jose, California. The order is firm fixed price with an ultimate completion date of April 6, 2018. No set-aside was applied.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Becton, Dickinson and Company (BD Biosciences) valued at $26,271.50 on April 20, 2020, for high parameter conjugates and HU CD197 antibody, with performance completed by April 19, 2021. Work is performed at Brea, California. This award was issued under the Coronavirus COVID-19 national interest action code and carries no small business set-aside.</p>

<p>The National Institute of Allergy and Infectious Diseases issued a delivery order to Becton, Dickinson and Company (BD Biosciences) on July 16, 2018, with a ceiling value of $10,335.00 for fluorescently conjugated monoclonal antibodies and flow cytometry custom conjugates for vaccine research and pre-clinical monitoring.</p> <p>Place of performance is San Jose, CA. The order is firm fixed price with an ultimate completion date of August 10, 2018. No set-aside was used.</p>

<p>The National Institute of Allergy and Infectious Diseases issued a delivery order to Becton, Dickinson And Company on June 13, 2019, with a ceiling value of $5,355.00 for fluorescently conjugated monoclonal antibodies and flow cytometry custom conjugates and consumables supporting vaccine research and pre-clinical monitoring.</p> <p>Place of performance is San Jose, CA. The order is firm fixed price and has an ultimate completion date of July 17, 2019. No set-aside was used.</p>

<p>The National Institute of Allergy and Infectious Diseases issued a delivery order to Becton, Dickinson and Company on March 22, 2019, with a ceiling value of $7,476.67 for fluorescently conjugated monoclonal antibodies and flow cytometry consumables supporting the Vaccine Research Center.</p> <p>Place of performance is San Jose, CA. Ultimate completion date is March 29, 2019. The order is firm fixed price with no set-aside.</p>

<p>The National Institute of Allergy and Infectious Diseases issued a delivery order to Becton, Dickinson and Company on June 4, 2018, with a ceiling value of $12,330.79 for fluorescently conjugated monoclonal antibodies and flow cytometry consumables for vaccine research and pre-clinical monitoring.</p> <p>Place of performance is San Jose, CA. The order was issued with an ultimate completion date of June 12, 2018. Pricing is firm fixed price with no set-aside applied.</p>

<p>The National Institute of Allergy and Infectious Diseases issued a $6,050 delivery order to Becton, Dickinson And Company (BD Biosciences division) on July 16, 2018, for fluorescently conjugated monoclonal antibodies and flow cytometry custom conjugates for vaccine research and pre-clinical monitoring.</p> <p>Place of performance is San Jose, CA. The order carries an ultimate completion date of August 10, 2018, and is priced on a firm fixed price basis. No set-aside was used.</p>

<p>The National Institute of Allergy and Infectious Diseases issued a delivery order to Becton, Dickinson and Company on August 30, 2018, with a ceiling value of $8,642.30 for fluorescently conjugated monoclonal antibodies for research and pre-clinical monitoring of vaccine applications and flow cytometry consumables.</p> <p>Place of performance is San Jose, CA. The order is firm fixed price with an ultimate completion date of September 11, 2018. No set-aside was used.</p>